EUVIMEDEUVIMED entdecken
Crossref

Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression

Long-Fei Wu, Zhi-Jiang Zhou, Yu-Heng Zeng, Sheng-Li Yang, Qing-Ying Zhang iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 2024

DOI: 10.1152/ajpgi.00255.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2024. Verfasst von Long-Fei Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Shantou University Medical College, Shantou, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Hepatocytes, RNA, Circular, Diet, High-Fat. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: GDSTC | Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CircRRM2 expression was downregulated in free fatty acid (FFA)-challenged hepatocytes and high-fat diet (HFD) fed mice. Overexpressed circular RNA ribonucleotide reductase subunit M2 (circRRM2) attenuated metabolic dysfunction-associated steatotic liver disease (MASLD) development by suppressing FFA-induced triglycerides accumulation. CircRRM2 targeted microRNA-142-5p (miR-142-5p), which served as an upstream inhibitor of neuregulin 1 (NRG1) and collaboratively regulated MASLD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsHepatocytesRNA, CircularDiet, High-FatNeuregulin-1AnimalsMiceMaleMice, Inbred C57BLFatty LiverHumansLiverNon-alcoholic Fatty Liver DiseaseRibonucleoside Diphosphate Reductase

Stichwörter der Autor:innen

circular RNA ribonucleotide reductase subunit M2metabolic dysfunction-associated steatotic liver diseasemicroRNA-142-5pneuregulin 1

Substanzen

MicroRNAsRNA, CircularMirn142 microRNA, mouseNeuregulin-1ribonucleotide reductase M2Ribonucleoside Diphosphate Reductase

Autor:innen und Institutionen

  • Department of Preventive Medicine, Shantou University Medical College, Shantou, People's Republic of China.
  • Department of Cardiology, People's Hospital of Xinjin District, Chengdu, People's Republic of China.
  • First Affiliated Hospital of Shantou University Medical College, Shantou, People's Republic of China.

ORCID-Profile: Qing-Ying Zhang

Förderung

  • GDSTC | Natural Science Foundation of Guangdong Province

Zitieren

APA

Wu, L. F., Zhou, Z. J., Zeng, Y. H., Yang, S. L., & Zhang, Q. Y. (2024). Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00255.2023

Vancouver

Wu LF, Zhou ZJ, Zeng YH, Yang SL, Zhang QY. Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024. doi:10.1152/ajpgi.00255.2023

BibTeX
@article{Wu2024,
  author = {Wu, Long-Fei and Zhou, Zhi-Jiang and Zeng, Yu-Heng and Yang, Sheng-Li and Zhang, Qing-Ying},
  title = {Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2024},
  doi = {10.1152/ajpgi.00255.2023}
}
Kostenlos starten →